Table 2

 Differences in outcome measures between the two study groups. Values are median (range, interquartile range)

10% Group (n = 25)50% Group (n = 26)Difference, p value
Total dose of dextrose (g)10 (5 to 30, 10 to 15)25 (10 to 25, 15 to 25)+15, p<0.001
Post-treatment blood glucose (mmol/l)6.20 (4 to 17, 5.15 to 9.10)9.40 (4.30 to 18.50, 8.28 to 11.60)+3.2, p = 0.003
Post-treatment GCS15 (6 to 15, 15 to 15)15 (3 to 15, 15 to 15)0, p = 0.400
Time to GCS 15 (min)8 (1 to 30, 5 to 15)8 (2 to 19, 4 to 11)0, p = 0.733
Time on scene (min)40 (13 to 75, 30 to 51)35 (15 to 61, 23 to 45)−5, p = 0.162
Ease of administration score2 (1 to 4, 1 to 3)1 (1 to 5, 1 to 2)−1, p = 0.142
Proportion (%)Proportion (%)Difference (95% CI, p value)
GCS, Glasgow Coma Scale
Subjects receiving the maximum permitted dose of 25 g3/25 (12%)17/26 (65%)+53% (+28 to +72%, p<0.0001)
Subjects with a post-treatment GCS of <152/25 (8%)1/26 (4%)−4% (−12 to +22%, p = 0.360)
Subjects with a further hypoglycaemic episode within 24 h4/22 (18%)4/22 (18%)0% (−24 to +24%, p = 1)